Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Athira Pharma, Inc. - Common Stock (NQ:ATHA)

7.500 +0.020 (+0.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 198,881
Open 7.300
Bid (Size) 7.280 (1,100)
Ask (Size) 7.480 (200)
Prev. Close 7.480
Today's Range 7.289 - 7.770
52wk Range 2.195 - 8.360
Shares Outstanding 38,054,583
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Athira Pharma Stock Shot Up 60% Today – What’s Triggering The Super Rally? ↗
Athira Pharma secured exclusive rights to a Phase 3 breast cancer drug and announced a $236 million financing package to support its development. 
Via Stocktwits
News headline image
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million
From Athira Pharma, Inc.
Via GlobeNewswire

Performance

YTD
+36.3%
+36.3%
1 Month
+76.5%
+76.5%
3 Month
+77.7%
+77.7%
6 Month
+148.3%
+148.3%
1 Year
+36.9%
+36.9%

More News

Read More
News headline image
Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
Athira Pharma Announces Reverse Stock Split
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
Athira (ATHA) Q2 Loss Narrows 74% ↗
Via The Motley Fool
News headline image
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Via Benzinga
News headline image
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
From Athira Pharma, Inc.
Via GlobeNewswire
News headline image
Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings ↗
Via Benzinga
News headline image
US Stocks Mixed; Trade Gap Widens In July ↗
Via Benzinga

Frequently Asked Questions

Is Athira Pharma, Inc. - Common Stock publicly traded?
Yes, Athira Pharma, Inc. - Common Stock is publicly traded.
What exchange does Athira Pharma, Inc. - Common Stock trade on?
Athira Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Athira Pharma, Inc. - Common Stock?
The ticker symbol for Athira Pharma, Inc. - Common Stock is ATHA on the Nasdaq Stock Market
What is the current price of Athira Pharma, Inc. - Common Stock?
The current price of Athira Pharma, Inc. - Common Stock is 7.500
When was Athira Pharma, Inc. - Common Stock last traded?
The last trade of Athira Pharma, Inc. - Common Stock was at 12/29/25 04:00 PM ET
What is the market capitalization of Athira Pharma, Inc. - Common Stock?
The market capitalization of Athira Pharma, Inc. - Common Stock is 285.41M
How many shares of Athira Pharma, Inc. - Common Stock are outstanding?
Athira Pharma, Inc. - Common Stock has 285M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.